⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9223567 | 1.00 | — | — | |
| Pyrimidine SCHEMBL28092233 | 0.88 | — | — | |
| SCHEMBL7892671 | 0.71 | — | — | |
| SCHEMBL4440463 | 0.70 | — | — | |
| SCHEMBL28185868 | 0.70 | — | — | |
| SCHEMBL31310667 | 0.68 | — | — | |
| SCHEMBL28131368 | 0.65 | — | — | |
| SCHEMBL28154865 | 0.60 | — | — | |
| SCHEMBL19286839 | 0.55 | — | — | |
| SCHEMBL18569705 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12297241-B2 | Method to engineer transplantable human tissues | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-05-13 | — | — | US | claimed |
| US-20220235104-A1 | NOVEL METHOD TO ENGINEER TRANSLANTABLE HUMAN TISSUES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-07-28 | — | — | US | claimed |
| EP-4720294-A2 | MODIFIED UNC13A OLIGONUCLEOTIDES | Quralis Corporation (US) | 2026-04-08 | — | — | EP | disclosed |
| US-12297241-B2 | Method to engineer transplantable human tissues | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-05-13 | — | — | US | disclosed |
| WO-2025097174-A1 | SPATIALLY ENCAPSULATED DNA ENCODED LIBRARIES AND METHODS OF SCREENING SAME | OM THERAPEUTICS, INC. (US) | 2025-05-08 | — | — | WO | disclosed |
| CN-119790152-A | Treatment of neurological disorders using modulators of UNC13A gene transcripts | 奎里斯公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-119522282-A | Splice transducer antisense oligonucleotides with modified backbone chemistry | 奎里斯公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-119452086-A | GAPMER antisense oligonucleotides with modified backbone chemistry | 奎里斯公司 | 2025-02-14 | — | — | CN | disclosed |
| WO-2024249791-A2 | MODIFIED UNC13A OLIGONUCLEOTIDES | QURALIS CORPORATION (US) | 2024-12-05 | — | — | WO | disclosed |
| US-20240368604-A1 | IL-34 ANTISENSE AGENTS AND METHODS OF USING SAME | NOGRA PHARMA LTD (IE) | 2024-11-07 | — | — | US | disclosed |
| EP-4441224-A1 | GAPMER ANTISENSE OLIGONUCLEOTIDES WITH MODIFIED BACKBONE CHEMISTRIES | Quralis Corporation (US) | 2024-10-09 | — | — | EP | disclosed |
| EP-0215942-B1 | POLYNUCLEOTIDE ASSAY REAGENT AND METHOD | ANTIVIRALS INC (US) | 1995-07-12 | — | — | EP | disclosed |
| EP-0639582-A2 | Polynucleotide assay reagent and method | ANTIVIRALS INC. (US) | 1995-02-22 | — | — | EP | disclosed |
| EP-0216860-B1 | STEREOREGULAR POLYNUCLEOTIDE-BINDING POLYMERS | SUMMERTON, James (US) | 1992-10-28 | — | — | EP | disclosed |
| EP-0216860-A4 | STEREOREGULAR POLYNUCLEOTIDE-BINDING POLYMERS. | SUMMERTON JAMES (US) | 1989-02-22 | — | — | EP | disclosed |
| EP-0215942-A4 | POLYNUCLEOTIDE ASSAY REAGENT AND METHOD. | SUMMERTON JAMES | 1988-08-23 | — | — | EP | disclosed |
| EP-0216860-A1 | STEREOREGULAR POLYNUCLEOTIDE-BINDING POLYMERS. | SUMMERTON JAMES (US) | 1987-04-08 | — | — | EP | disclosed |
| EP-0215942-A1 | POLYNUCLEOTIDE ASSAY REAGENT AND METHOD. | SUMMERTON JAMES | 1987-04-01 | — | — | EP | disclosed |
| WO-1986005518-A1 | STEREOREGULAR POLYNUCLEOTIDE-BINDING POLYMERS | SUMMERTON JAMES | 1986-09-25 | — | — | WO | disclosed |
| WO-1986005519-A1 | POLYNUCLEOTIDE ASSAY REAGENT AND METHOD | SUMMERTON JAMES | 1986-09-25 | — | — | WO | disclosed |